Skip to search.
 All Ordinaries Down 1.11%

More On MBLTY

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Mesoblast Limited (MBLTY)

-Other OTC
12.33 0.00(0.00%) 30 Oct 00:30
Prev Close:12.33
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:37.16
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:10.27 - 19.00
Volume:0
Avg Vol (3m):1,111
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Press Releases

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative therapeutic cell-based products in Australia, the United States, and Singapore. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback